Clincosm LogoSign in Get a demo

Estrogen Receptor Positive

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in Guam, Puerto Rico, United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Usual care disease monitoring
  • +3 more
  • Anchorage, Alaska
  • +706 more
Jan 24, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial

Withdrawn
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +28 more
  • Carbon Dioxide Fractional Laser
  • Questionnaire Administration
  • (no location specified)
Jan 5, 2023

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,

Active, not recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Atlanta, Georgia
  • +9 more
Oct 12, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Active, not recruiting
Has Results
  • Anatomic Stage II Breast Cancer AJCC v8
  • +16 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive, Invasive Breast Carcinoma Trial in United States (Accelerated

Active, not recruiting
Has Results
  • Ductal Breast Carcinoma In Situ
  • +6 more
  • Accelerated Partial Breast Irradiation
  • +2 more
  • Gilbert, Arizona
  • +9 more
Jul 20, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Breast Carcinoma, Estrogen Receptor Positive Trial in Palo Alto (drug, procedure, device)

Suspended
  • Breast Carcinoma
  • Estrogen Receptor Positive
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Dec 8, 2021

Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in Seattle (procedure, drug,

Terminated
Has Results
  • Estrogen Receptor Positive
  • +2 more
  • Computed Tomography
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 28, 2021

Adult Women, Metastatic Breast Cancer, Estrogen Receptor Positive Trial in Maywood (Cholecalciferol)

Completed
Has Results
  • Adult Women
  • +2 more
  • Maywood, Illinois
    Loyola University Medical Center
May 12, 2021

Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive Trial in United States (Afimoxifene, Laboratory Biomarker Analysis,

Recruiting
  • Ductal Breast Carcinoma In Situ
  • Estrogen Receptor Positive
  • Chicago, Illinois
  • +5 more
Dec 17, 2020

Advanced Malignant Solid Tumor, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (drug, other, biological)

Completed
  • Advanced Malignant Solid Neoplasm
  • +12 more
  • Houston, Texas
  • +4 more
Dec 16, 2020

Estrogen Receptor Positive, Obesity, Progesterone Receptor Positive Trial in Los Angeles (dietary supplement, behavioral, other)

Withdrawn
  • Estrogen Receptor Positive
  • +5 more
  • Dietary Intervention
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 15, 2020

Breast Adenocarcinoma, Estrogen Receptor Positive, HER2/Neu Negative Trial in Tampa, Bronx (drug, other, procedure)

Terminated
  • Breast Adenocarcinoma
  • +8 more
  • Tampa, Florida
  • +1 more
Sep 22, 2020

Breast Cancer, Metastatic Breast Cancer, MBC Trial in United States (Lucitanib)

Terminated
Has Results
  • Breast Cancer
  • +7 more
  • Sedona, Arizona
  • +32 more
Jun 20, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive Trial in Houston (Imatinib Mesylate,

Completed
Has Results
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2020

Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (Fulvestrant, Laboratory

Completed
Has Results
  • Estrogen Receptor Positive
  • +7 more
  • Little Rock, Arkansas
  • +367 more
Dec 9, 2019

Ductal Breast Carcinoma, Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative Trial in Buffalo (Broccoli Sprout Extract,

Completed
  • Ductal Breast Carcinoma
  • +10 more
  • Broccoli Sprout Extract
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 29, 2019

Cancer Survivor, Central Obesity, Estrogen Receptor Positive Trial in Los Angeles (Exercise Intervention, Informational

Withdrawn
  • Cancer Survivor
  • +14 more
  • Exercise Intervention
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Oct 21, 2019

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Completed
  • Anatomic Stage II Breast Cancer AJCC v8
  • +18 more
  • Exercise Intervention
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 19, 2019

Breast Carcinoma Metastatic in the Bone, Circulating Tumor Cell Count, Estrogen Receptor Positive Trial in Chicago, Lake Forest

Terminated
Has Results
  • Breast Carcinoma Metastatic in the Bone
  • +5 more
  • Denosumab
  • Laboratory Biomarker Analysis
  • Chicago, Illinois
  • +1 more
Oct 22, 2018

Estrogen Receptor Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Rochester (Alisertib,

Completed
  • Estrogen Receptor Positive
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 2, 2018